NDC codes

FDA NDC Directory
Product NDC (as listed)50102-254Labeler and product segments. Claims need a package NDC.
Product NDC at billing width50102-0254Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
50102-254-23501020254233 POUCH in 1 CARTON (50102-254-23) / 1 BLISTER PACK in 1 POUCH (50102-254-21) / 1 KIT in 1 BLISTER PACKMarketed from May 17, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Cyred EQ
Generic name (nonproprietary)
desogestrel and ethinyl estradiol
Dosage form
Kit
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 207081
Marketing start
Listing expires
Identifiers
Product ID 50102-254_9c923303-f770-44a5-ab6c-358aa68b25ffSPL ID 9c923303-f770-44a5-ab6c-358aa68b25ffSPL set ID 2417aee4-6838-4ea6-8e0d-3144f522310cRxCUI 240707, 748797, 749848, 1660690

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N450102025423 followed by a unit qualifier and the quantity

Package 50102-0254-23. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Cyred EQ ® tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective. Table 1 lists the typical accidental pregnancy rates for users of combined oral contraceptives and other methods of contraception. The efficacy of these contraceptive methods, except sterilization, the IUD, and the Norplant System depends upon the reliability with which they are used. Correct and consistent use of these methods can result in lower failure rates. In a clinical trial with Cyred EQ ® , 1,195 subjects completed 11,656 cycles and a total of 10 pregnancies were reported. This rep…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 207081

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207081
ProductStrengthForm · routeLabelerProduct NDC
Cyred EQdesogestrel and ethinyl estradiol—KitBryant Ranch Prepack63629-5649
Kalligadesogestrel and ethinyl estradiol—KitAurobindo Pharma Limited65862-887

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in